1992
DOI: 10.1002/hep.1840150531
|View full text |Cite
|
Sign up to set email alerts
|

Sequence of Exons and the Flanking Regions of Human Bilirubin–Udp–Glucuronosyltransferase Gene Complex and Identification of A Genetic Mutation in A Patient With Crigler–Najjar Syndrome, Type I

Abstract: Crigler-Najjar syndrome, type I is a heterogeneous disorder that may result from mutations of various regions of the bilirubin-UDP-glucuronosyltransferase gene complex that encodes two bilirubin-UDP-glucuronosyltransferase isoforms and a phenol-UDP-glucuronosyltransferase isoform in the human liver. The two bilirubin-UDP-glucuronosyltransferase messenger RNAs and the phenol-UDP-glucuronosyltransferase messenger RNA have identical 3' regions derived from four consecutive exons. The 5' region of each messenger R… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
95
0

Year Published

1994
1994
2009
2009

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 183 publications
(96 citation statements)
references
References 25 publications
1
95
0
Order By: Relevance
“…This appears to be supported by the data so far available concerning sequence alterations in UGTI associated with CN-I. These alterations include a 13-base frameshift deletion in exon 2 (12), and point mutations in exons 2 (13) and 3 (14). For all ofthe mutations, especially in cases where the suspected mutation is a potentially silent mutation, both biochemical and genetic criteria are required to associate a given mutation in UGTI with the inactivation of bilirubin UDPGT and the onset of CN-I disease.…”
Section: Introductionsupporting
confidence: 52%
“…This appears to be supported by the data so far available concerning sequence alterations in UGTI associated with CN-I. These alterations include a 13-base frameshift deletion in exon 2 (12), and point mutations in exons 2 (13) and 3 (14). For all ofthe mutations, especially in cases where the suspected mutation is a potentially silent mutation, both biochemical and genetic criteria are required to associate a given mutation in UGTI with the inactivation of bilirubin UDPGT and the onset of CN-I disease.…”
Section: Introductionsupporting
confidence: 52%
“…On the basis of the structure of the gene for human bilirubin UGT, the genetic backgrounds of patients with CN-I have been elucidated. While almost all reported patients with the disease have homozygous nonsense or deletion mutations in the coding region of the gene (Brierley and Burchell, 1993), a few cases with homozygous missense mutations were found recently (Bosma et al, 1992b;Erps et al, 1994). By screening, we found four patients who suffered from CN-I in Japan.…”
mentioning
confidence: 93%
“…The first mutation in this gene was described in 1992. It was a nonsense mutation found in homozygosity in a patient with Crigler -Najjar syndrome [6]. Only in 1995 were mutations in this gene found to be correlated with Gilbert syndrome [7].…”
Section: Introductionmentioning
confidence: 99%